Kanli A, Sunnetci-Akkoyunlu D, Kulcu-Sarikaya N, Ugurtas C, Akpinar G, Kasap M
In Vivo. 2025; 39(2):795-809.
PMID: 40010958
PMC: 11884493.
DOI: 10.21873/invivo.13863.
Iida K, Okada M
Cancers (Basel). 2024; 16(10).
PMID: 38791962
PMC: 11119661.
DOI: 10.3390/cancers16101884.
Huang Q, Zhou J, Wang Z, Yang K, Chen Z
Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(3):578-584.
PMID: 38597450
PMC: 11006701.
DOI: 10.12122/j.issn.1673-4254.2024.03.20.
Wang Y, Zhu W, Ma R, Tian Y, Chen X, Gao P
J Cell Mol Med. 2023; 28(1):e18022.
PMID: 37929660
PMC: 10805483.
DOI: 10.1111/jcmm.18022.
Li Y, Patterson M, Morgan E, Wasson C, Ryder E, Barba-Moreno D
J Med Virol. 2023; 95(8):e29025.
PMID: 37565725
PMC: 10952218.
DOI: 10.1002/jmv.29025.
A short peptide LINC00665_18aa encoded by lncRNA LINC00665 suppresses the proliferation and migration of osteosarcoma cells through the regulation of the CREB1/RPS6KA3 interaction.
Pan J, Liu M, Duan X, Wang D
PLoS One. 2023; 18(6):e0286422.
PMID: 37285335
PMC: 10246827.
DOI: 10.1371/journal.pone.0286422.
Neobaicalein prevents isoflurane anesthesia-induced cognitive impairment in neonatal mice via regulating CREB1.
Wu N, Liu H, Lv X, Sun Y, Jiang H
Clinics (Sao Paulo). 2023; 78:100201.
PMID: 37120983
PMC: 10173397.
DOI: 10.1016/j.clinsp.2023.100201.
Target Finder of Transcription Factor (TFoTF): a novel tool to predict transcription factor-targeted genes in cancer.
Wang F, Xu X, Li X, Yuan J, Gao X, Wang C
Mol Oncol. 2023; 17(7):1246-1262.
PMID: 36734611
PMC: 10323881.
DOI: 10.1002/1878-0261.13388.
Combination of 7--geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer.
Chen Y, Li X, Shi L, Ma P, Wang W, Wu N
Aging (Albany NY). 2022; 14(17):7156-7169.
PMID: 36107024
PMC: 9512499.
DOI: 10.18632/aging.204287.
A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone.
Fu Y, Xin Z, Ling Z, Xie H, Xiao T, Shen X
Mol Med. 2021; 27(1):81.
PMID: 34294046
PMC: 8296714.
DOI: 10.1186/s10020-021-00341-z.
Competing Endogenous RNA Networks in Glioma.
Cen L, Liu R, Liu W, Li Q, Cui H
Front Genet. 2021; 12:675498.
PMID: 33995499
PMC: 8117106.
DOI: 10.3389/fgene.2021.675498.
acts via the miR‑922/ axis to enhance malignant behavior of liver cancer cells.
Liu X, Zhang H, Zhou P, Yu Y, Zhang H, Chen L
Oncol Rep. 2021; 45(5).
PMID: 33786634
PMC: 8020205.
DOI: 10.3892/or.2021.8030.
CREB1 Suppresses Transcription of microRNA-186 to Promote Growth, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells Through the KRT8/HIF-1α Axis.
Huang X, Liu F, Jiang Z, Guan H, Jia Q
Cancer Manag Res. 2020; 12:9097-9111.
PMID: 33061604
PMC: 7526476.
DOI: 10.2147/CMAR.S265187.
miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma.
Li J, Liu X, Wang W, Li C
Arch Med Sci. 2020; 16(4):941-956.
PMID: 32542098
PMC: 7286343.
DOI: 10.5114/aoms.2019.86901.
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.
Friedrich M, Heimer N, Stoehr C, Steven A, Wach S, Taubert H
Sci Rep. 2020; 10(1):6499.
PMID: 32300145
PMC: 7162877.
DOI: 10.1038/s41598-020-63403-y.
The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast Carcinoma.
Pu Q, Lu L, Dong K, Geng W, Lv Y, Gao H
J Mammary Gland Biol Neoplasia. 2020; 25(1):37-50.
PMID: 32026099
DOI: 10.1007/s10911-020-09443-6.
CREB5 promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
Wu J, Wang S, Zhang Z, Zhou Q, Peng B
Int J Clin Exp Pathol. 2020; 11(10):4908-4916.
PMID: 31949566
PMC: 6962929.
Homo Sapiens Circular RNA 0079993 (hsa_circ_0079993) of the POLR2J4 Gene Acts as an Oncogene in Colorectal Cancer Through the microRNA-203a-3p.1 and CREB1 Axis.
Lu X, Yu Y, Liao F, Tan S
Med Sci Monit. 2019; 25:6872-6883.
PMID: 31515467
PMC: 6755939.
DOI: 10.12659/MSM.916064.
C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
Zhang B, Zhang P, Tan Y, Feng P, Zhang Z, Liang H
Cell Death Dis. 2019; 10(7):520.
PMID: 31285424
PMC: 6614451.
DOI: 10.1038/s41419-019-1749-0.
miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
Wang Y, Zhao S, Yuan X, Liu Y, Zhang K, Wang J
J Cell Mol Med. 2019; 23(4):2549-2557.
PMID: 30701690
PMC: 6433729.
DOI: 10.1111/jcmm.14145.